Showing 1 - 20 results of 25 for search 'The Greatest Canadian', query time: 0.04s Refine Results
  1. 1

    Characterization of Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals: Results of the CANWARD 2007 Study by Andrew Walkty, Melanie DeCorby, Kim Nichol, Melissa McCracken, Michael R Mulvey, James A Karlowsky, Daryl J Hoban, George G Zhanel

    Published 2009-01-01
    “…CONCLUSIONS: P aeruginosa is common among clinical specimens from patients in Canadian hospitals. Of the antipseudomonal antimicrobials evaluated, amikacin, meropenem and piperacillin/tazobactam demonstrated the greatest in vitro activity. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Update on Nonsurgical Lung Volume Reduction Procedures by J. Alberto Neder, Denis E. O’Donnell

    Published 2016-01-01
    “…ELVR procedures are currently available in selected Canadian research centers as part of ethically approved clinical trials. …”
    Get full text
    Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Bioterrorism in Canada: An Economic Assessment of Prevention and Postattack Response by Ronald St John, Brian Finlay, Curtis Blair

    Published 2001-01-01
    “…The present paper calculates the human and economic consequences of a bioterrorist attack on Canadian soil using aerosolized Bacillus anthracis and Clostridium botulinum. …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18
  19. 19

    Central Venous Catheter-Associated Bloodstream Infections in Hemodialysis Patients: Another Patient Safety Bundle? by B Lynn Johnston, John M Conly

    Published 2006-01-01
    “…In a previous issue of The Canadian Journal of Infectious Diseases & Medical Microbiology, we reviewed the 'Safer Healthcare Now!' …”
    Get full text
    Article
  20. 20

    Retrospective Cohort Analysis of Outpatient Antibiotic Use for Clostridioides difficile-Indicated Agents in British Columbia, from 2000 to 2018 by Ariana Saatchi, Sungeun Kim, Fawziah Marra

    Published 2023-01-01
    “…Vancomycin had the highest percentage increase (621%), with the greatest change occurring from 2014 to 2015, correlating to the dissemination of new clinical practice guidelines. …”
    Get full text
    Article